Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CAR T-Cell Transplant”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT04817774
What this trial is testing

Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients

Who this might be right for
Kidney Transplant RejectionEnd Stage Renal Disease
Sangamo Therapeutics 26
Testing effectiveness (Phase 2)Looking for participantsNCT06247501
What this trial is testing

Treatment of CD19 Chimeric Antigen Receptor T Cells for Pediatric Patients With CD19-positive B-cell Acute Lymphoblastic Leukemia Who Are Indicated for Hematopoietic Stem Cell Transplantation

Who this might be right for
Very High Risk Acute Lymphoblastic LeukemiaCD19 CAR-T Therapy
Seoul National University Hospital 50
Very early researchNot Yet RecruitingNCT07201727
What this trial is testing

CD123+CLL-1 CAR-T Sequential Infusion With CD7 CAR-T and Bridging to Allo-HSCT for Relapsed/Refractory Acute Myeloid Leukemia

Who this might be right for
AML - Acute Myeloid Leukemia
Institute of Hematology & Blood Diseases Hospital, China 10
Testing effectiveness (Phase 2)UnknownNCT03366324
What this trial is testing

Anti-CD19 CAR-T Therapy Combine With HSCT to Treat MRD+ B-cell Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaB Cell Lymphoma
Wuhan Sian Medical Technology Co., Ltd 20
Early research (Phase 1)UnknownNCT05679687
What this trial is testing

ThisCART19A Bridging to alloHSCT for R/R B-ALL

Who this might be right for
CARRefractory Acute Lymphoblastic LeukemiaRelapsed Adult ALL
The First Affiliated Hospital of Soochow University 20
Not applicableActive Not RecruitingNCT06760936
What this trial is testing

Pixantrone as Bridging Therapy to Allogenic Transplant or CAR-T Cell Therapy in DLBCL Patients

Who this might be right for
Diffuse Large B Cell Lymphoma (DLBCL)
IRCCS Azienda Ospedaliero-Universitaria di Bologna 15
Not applicableLooking for participantsNCT06575712
What this trial is testing

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

Who this might be right for
Hematopoietic Stem Cell TransplantCAR-T Cell Therapy
Duke University 177
Not applicableUnknownNCT03423706
What this trial is testing

Clinical Studies of New Model Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
CD19-chimeric Antigen Receptor T CellsRelapsed and/or Refractory Acute Lymphoblastic Leukemiathe Haploidentical Hematopoietic Stem Cell Transplantation
First Affiliated Hospital of Harbin Medical University 50
Post-approval studies (Phase 4)Not Yet RecruitingNCT07296120
What this trial is testing

RSV Vaccine Response in Stem Cell and CAR-T Therapy Recipients

Who this might be right for
CAR-T Cell TherapyRSV ImmunizationBone Marrow Transplant - Autologous or Allogeneic
The Cooper Health System 30
Testing effectiveness (Phase 2)Ended earlyNCT05984199
What this trial is testing

Donor-Derived Anti-CD33 CAR T Cell Therapy (VCAR33) in Patients With Relapsed or Refractory AML After Allogeneic Hematopoietic Cell Transplant

Who this might be right for
Leukemia, Myeloid, Acute
Vor Biopharma 38
Testing effectiveness (Phase 2)Ended earlyNCT06381830
What this trial is testing

Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma, B-CellAutologous Stem Cell Transplantation
The First Affiliated Hospital of Soochow University 8
Testing effectiveness (Phase 2)Looking for participantsNCT06793449
What this trial is testing

BCMA CAR-T Versus ASCT in Transplant-eligible Patients With Multiple Myeloma

Who this might be right for
Multiple Myeloma
Institute of Hematology & Blood Diseases Hospital, China 80
Early research (Phase 1)UnknownNCT03110640
What this trial is testing

Anti-CD19 CAR T Infusion Combined With Allogeneic Stem Cell Transplantation for B-cell Leukemia/Lymphoma

Who this might be right for
B-cell Adult Acute Lymphoblastic LeukemiaB-cell Chronic Lymphocytic LeukemiaAdult Acute Lymphoblastic Leukemia in Remission+2 more
First Affiliated Hospital of Wenzhou Medical University 20
Not applicableLooking for participantsNCT01166009
What this trial is testing

CIBMTR Research Database

Who this might be right for
Autologous Stem Cell TransplantationAllogeneic Stem Cell TransplantationSolid Tumors+4 more
Center for International Blood and Marrow Transplant Research 99,999,999
Early research (Phase 1)Active Not RecruitingNCT05942599
What this trial is testing

Base Edited CAR T Cells Against AML: Deep Conditioning Ahead of Allogeneic Stem Cell Transplantation

Who this might be right for
Relapsed Acute Myeloid Leukaemia
Great Ormond Street Hospital for Children NHS Foundation Trust 10
Early research (Phase 1)Not Yet RecruitingNCT07166549
What this trial is testing

Bispecific CAR T Cells for B-cell Malignancies (BaseCAR-01 Trial)

Who this might be right for
B Cell MalignanciesB-cell LeukemiaB Cell Lymphoma+2 more
University Hospital, Basel, Switzerland 12
Testing effectiveness (Phase 2)Looking for participantsNCT04276870
What this trial is testing

Orphan Indications for CD19 Redirected Autologous T Cells

Who this might be right for
Pediatric and Young Adult Patientswith Hypodiploid or t(17;19) B-ALLInfants With Very High Risk KMT2A B-ALLPatients With Central Nervous System Relapse Who Did Not Receive Cranial Radiation or Bone Marrow Transplantation
Stephan Grupp MD PhD 133
Testing effectiveness (Phase 2)Study completedNCT04690192
What this trial is testing

CNCT19 Following ASCT in Patients With Relapsed or Refractory B-cell Lymphoma

Who this might be right for
Large B-cell Lymphoma
Institute of Hematology & Blood Diseases Hospital, China 30
Early research (Phase 1)Active Not RecruitingNCT05753501
What this trial is testing

Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies

Who this might be right for
Hematologic Cancer
AbbVie 135
Early research (Phase 1)UnknownNCT04516551
What this trial is testing

Anti-CD19 Allo-CAR-T Cells for Relapsed B Cell Malignancies After HSCT

Who this might be right for
Relapsed Adult ALLB Cell Leukemia
Xinqiao Hospital of Chongqing 18
Next Page